A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

Influential factors impacting treatment (tx) decision making (TDM) and decision regret (DR) in patients (pts) with localized or locally advanced prostate cancer (LPC/LAPC).

How can artificial intelligence (AI) help medical professionals identify, diagnose, and treat prostate cancer? This is what a recent study published in Radiology hopes to address as a team of ...

Tumor heterogeneity, which refers to variations in the cellular and genetic components between cancer cells within a tumor, can complicate the determination of optimal treatment approaches for ...

Predicting the course of prostate cancer is challenging because only a fraction of prostate cancer patients experience recurrence after radical prostatectomy or radiation therapy. Yet, prostate cancer ...

A new preclinical model using CRISPR, an advanced technology that allows scientists to cut and edit genes, has given researchers a deeper insight into how prostate cancer spreads or metastasizes. A ...

Dogs are proving to be a far better scientific model for study of prostate cancer than mice, the typical animal used in the lab for this type of research. In the first use of canines in an advanced ...

Prostate cancer is a quiet killer. In most men, it's treatable. However, in some cases, it resists all known therapies and turns extremely deadly. Published in the journal Science, a new discovery at ...

New research from Cold Spring Harbor Labs shows that a compound related to vitamin K slowed the progression of prostate cancer in lab mice, offering a path for further study into one of the most ...